Atlas Trials

Tick-borne Encephalitis

23 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Tick-borne Encephalitis

RecordFirmDate
Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older (NCT04648241)Pfizer2021-01-18
Application of a TBE-Vaccine in Obese Persons (NCT04017052)Medical University of Vienna2015-04-15
New Study - Humoral Response to Tick-borne Encephalitis Vaccine in Elderly (NCT02318069)Sormland County Council, Sweden2015-01-01
Tick-borne Encephalitis and Positive Borrelial Antibodies (NCT02463942)University Medical Centre Ljubljana2014-09-01
Tick-borne Encephalitis and Borrelial Antibodies in Serum (NCT03956446)University Medical Centre Ljubljana2014-09-01
Humoral and Cellular Immunity for TBE Vaccination in Allogeneic HSCT Recipients (NCT01991067)Medical University of Vienna2014-07-01
Cervicovaginal Immune Responses to 3 Deltoid or Thigh Intramuscular (IM) TicoVac (NCT01710189)University of Surrey2012-10-01
Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination Schedules (NCT01562444)GlaxoSmithKline2012-03-08
Humoral Response to Tick-borne Encephalitis Vaccine in Elderly (NCT01361776)Sormland County Council, Sweden2011-09-01
Humoral and Cellular Immunity of Low and High-responders After Tick-borne Encephalitis Vaccination (NCT00804219)Medical University of Vienna2008-12-01
Evaluation of Immunogenicity of Different Tick Borne Encephalitis (TBE) Fast Protective Traveler Schemes With Inactivated TBE Whole Virus Vaccine (NCT00890422)Elisabethinen Hospital2007-03-01
Tick-borne Encephalitis and Possible Borrelial Serology (NCT03958058)University Medical Centre Ljubljana2007-01-01
Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults (NCT00118924)National Institute of Allergy and Infectious Diseases (NIAID)2005-07-01
Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years (NCT00161863)Pfizer2002-09-01
Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years. (NCT00161772)Pfizer2002-03-01
Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years. (NCT00161798)Pfizer2001-09-01

Track Tick-borne Encephalitis automatically

Every clearance here is in the API, with alerts when new ones post.